Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 465 entries
View as:

A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00266604 Org: User:
Start: 12/31/05 End: 06/30/07 Due: 06/30/08

A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00576732 Org: User:
Start: 12/31/07 End: 03/31/10 Due: 03/31/11

A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00236561 Org: User:
Start: 04/30/01 End: 12/31/02 Due: 12/31/03

A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00211133 Org: User:
Start: 06/30/00 End: 12/31/06 Due: 12/31/07

A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.

Phase: N/A Priority: Normal
NCT ID: NCT00337935 Org: User:
Start: 07/31/06 End: 07/31/09 Due: 07/31/10

A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00231621 Org: User:
Start: 05/31/01 End: 06/30/02 Due: 06/30/03

24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00752427 Org: User:
Start: 06/30/04 End: 11/30/05 Due: 11/30/06

Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)

Phase: N/A Priority: Normal
NCT ID: NCT00091910 Org: User:
Start: 09/30/03 End: 06/30/06 Due: 06/30/07

A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Phase: N/A Priority: Normal
NCT ID: NCT00132678 Org: User:
Start: 02/28/05 End: 12/31/07 Due: 12/31/08

Effect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT01487512 Org: User:
Start: 03/31/11 End: 07/31/11 Due: 07/31/12

An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT00210834 Org: User:
Start: 05/31/04 End: 09/30/05 Due: 09/30/06

A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00890292 Org: User:
Start: 05/31/09 End: 12/31/09 Due: 12/31/10

A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

Phase: N/A Priority: Normal
NCT ID: NCT00377988 Org: User:
Start: 04/30/02 End: 10/31/08 Due: 10/31/09

A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00210561 Org: User:
Start: 03/31/05 End: 04/30/05 Due: 04/30/06

A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01309425 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00821600 Org: User:
Start: 12/31/08 End: 06/30/09 Due: 06/30/10

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00266617 Org: User:
Start: - End: 06/30/90 Due: 06/30/91

A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00361504 Org: User:
Start: 11/30/06 End: 07/31/08 Due: 07/31/09

Tapentadol (CG5503)

Phase: N/A Priority: Normal
NCT ID: NCT00421928 Org: User:
Start: 01/31/07 End: 12/31/08 Due: 12/31/09

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00034762 Org: User:
Start: 12/31/00 End: 01/31/03 Due: 01/31/04

A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT00077727 Org: User:
Start: 03/31/03 End: 02/28/05 Due: 02/28/06

A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

Phase: N/A Priority: Normal
NCT ID: NCT00231530 Org: User:
Start: 01/31/01 End: 05/31/02 Due: 05/31/03

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00082602 Org: User:
Start: 05/31/04 End: 04/30/05 Due: 04/30/06

A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone

Phase: N/A Priority: Normal
NCT ID: NCT00796432 Org: User:
Start: 03/31/03 End: 06/30/03 Due: 06/30/04

A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00231660 Org: User:
Start: 10/31/00 End: 06/30/02 Due: 06/30/03